l General Information |
Product Name | Anagrelide |
General description | Anagrelide is a Platelet-reducing Agent. The mechanism of action of anagrelide is as a Phosphodiesterase 3 Inhibitor. |
Purity | ≥98.0%(HPLC) | CAS Number | 68475-42-3 |
Formula | C10H7Cl2N3O | Molecular Weight | 256.09 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or off-white to pale yellow solid |
l Biological Information |
Biochem/Physiol
Actions | Anagrelide is a drug used for the treatment of essential thrombocytosis (ET; essential thrombocythemia). It works by inhibiting the maturation of megakaryocytes into platelets. Although its exact mechanism of action is not fully understood, it is proposed to primarily work by inhibiting the phosphodiesterase-III enzyme. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not
for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
